A new animal model for Epstein-Barr virus pathogenesis

Current Topics in Microbiology and Immunology

Volumn 258, Issue , 2001, Pages 201-219

  Wang, F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; B LYMPHOCYTE; CELL IMMORTALIZATION; EPSTEIN BARR VIRUS; HERPES VIRUS; IMMUNE RESPONSE; MACACA; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; SIMIAN VIRUS; VIRUS PATHOGENESIS;

ANIMALIA; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; MACACA; SIMIAE; SIMIAN VIRUS;

EID: 0034971872     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-56515-1_13     Document Type: Review

References (79)

1. Oncogenic herpesviruses of nonhuman primates
2. The establishment of continuous lymphoblastoid suspension cell cultures from hematopoietic organs of baboon (Papio hamadryas) with malignant lymphoma
3. Morphology immunophenotype and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual infection route of Epstein-Barr virus
4. Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes
5. Morphological characteristics of Epstein-Barr virus-related early gastric carcinoma: A case-control study
6. Squamous epithelial proliferative lesions associated with rhesus Epstein-Barr virus in simian immunodeficiency virus-infected rhesus monkeys
7. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologs of Epstein-Barr virus nuclear antigen 1
8. Characterization of an EBV-like virus from African green monkey lymphoblasts
9. Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains
10. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals
11. Direct visualization of antigen-specific CD8 + T cells during the primary immune response to Epstein-Barr virus in vivo
12. Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus
13. Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells
14. The value of specific pathogen-free rhesus monkey breeding colonies for AIDS research
15. Nuclear DNA-binding proteins determined by the Epstein-Barr virus-related simian lymphotropic herpesviruses H. gorilla, H. pan, H. pongo and H. papio
16. Immunofluorescence tests for antibodies to Epstein-Barr virus with sera of lower primates
17. Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine
18. Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus
19. Epstein-Barr virus: Transformation of non-human primate lymphocytes in vitro
20. Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus
21. Epstein-Barr virus and nonhuman primates: Natural and experimental infection
22. 5′ Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio
23. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1
24. Biologic and antigenic characteristics of Epstein-Barr virus-related herpesviruses of chimpanzees and baboons
25. Antigens and DNA of a chimpanzee agent related to Epstein-Barr virus
26. Isolation of a primate type-C virus from a lymphomatous baboon
27. First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen
28. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation
29. Establishment of a lymphoblastoid cell line from a lymphomous cynomolgus monkey
30. DNA of herpesvirus pan a third member of the Epstein-Barr virus-Herpesvirus papio group
31. Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA
32. Colinearity between the DNAs of Epstein-Barr virus and herpesvirus papio
33. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children
34. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus
35. EBV antibody in sera of non-human primates
36. EBV antibody in monkeys and apes
37. Host responses to lymphocryptovirus infection in rhesus macaques-an animal model for EBV infection
38. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: Implications for vaccine development
39. Herpes-type virus in cultured leukocytes from chimpanzees
40. Seroepidemiologic studies of Epstein-Barr virus antibody in monkeys
41. The epidemiologic and genetic aspect of an outbreak of leukemia among baboons of the Sukhumi monkey colony in Dutcher and Chieco-Bianchi. Unifying concepts of leukemia
42. Herpesvirus HVMA: A new representative in the group of the EBV-like B- lymphotropic herpesviruses of primates
43. The Epstein-Barr virus determined nuclear antigens EBNA-3A -3B and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter
44. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
45. Expression of Epstein-Barr-virus-related nuclear antigens and B-cell markers in lymphomas of SIV-immunosuppressed monkeys
46. Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk
47. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B
48. BHRF1 the Epstein-Barr virus gene with homology to Bcl2 is dispensable for B-lymphocyte transformation and virus replication
49. Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus
50. An animal model for acute and persistent Epstein-Barr virus infection
51. Viral pathogenesis in hu-PBL-SCID mice
52. Establishment of a lymphoblastoid cell line and isolation of an Epstein-Barr-related virus of gorilla origin
53. Neoplasms of the hematopoietic system in nonhuman primates: Report of one spontaneous tumor and two leukemias induced by procarbazine
54. Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses
55. In vitro lymphocyte transformation by Epstein-Barr virus (EBV)-like viruses isolated from Old-World non-human primates
56. Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease
57. Further characterization of a herpesvirus-positive orang-utan cell line and comparative aspects of in vitro transformation with lymphotropic old world primate herpesviruses
58. Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma
59. Acute and persistent viral loads using real-time PCR after experimental lymphocryptovirus infection of rhesus monkeys
60. Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections
61. Establishment of a cell line with associated Epstein-Barr-like virus from a leukemic orangutan
62. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys
63. Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homolog in the rhesus lymphocryptovirus
64. Epstein-Barr virus vectors for gene delivery to B lymphocytes
65. Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII
66. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells
67. Epstein-Barr virus and carcinomas: Rare association of the virus with gastric adenocarcinomas
68. Mechanisms that regulate Epstein-Barr virus EBNA-I gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates
69. Inability to detect hepatitis B virus or specific antigens in transformed chimpanzee lymphocytes
70. Detection of a second widespread strain of Epstein-Barr virus
71. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response
72. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory
73. Comparison of antigens from human and chimpanzee herpes-type virus-infected hemic cell lines
74. Epstein-Barr virus recombinants with specifically mutated BCRF1 genes
75. Epstein-Barr virus-encoded small RNAs (EBERs) do not modulate interferon effects in infected lymphocytes
76. Human and viral interleukin-10 in acute Epstein-Barr virus-induced infectious mononucleosis
77. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro
78. Epstein-Barr Virus and Human Herpesvirus-8
79. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function